{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:25:20Z","timestamp":1790007920604,"version":"4.0.1"},"reference-count":49,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n With shorter window periods than serologic point-of-care (POC) tests and faster turnaround than laboratory-based nucleic acid tests (NAT), POC NATs could improve early detection of HIV. Furthermore, semiquantitative POC NAT may provide real-time monitoring for persons with HIV. There have been limited evaluations of POC NAT implementation in the United States.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This paper describes the protocols and procedures used to evaluate the acceptability and feasibility of POC NAT implementation and test performance in clinical and community settings in Seattle, Washington.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The Greater Access and Impact through POC NAT (GAIN) study was a Centers for Disease Control and Prevention\u2013funded study that enrolled participants at a Ryan White\u2013funded, hospital-based clinic (Madison Clinic) and a community site (Seattle\u2019s LGBTQ+ Center [the Center]). Persons seeking HIV testing, nonoccupational postexposure prophylaxis, or pre-exposure prophylaxis (PrEP) enrolled at either site received the standard of care plus the SAMBA II HIV-1 Qualitative Whole Blood Test (SAMBA Qual) and pooled laboratory HIV NAT, and persons with HIV enrolled at the Center received standard-of-care sexually transmitted infection testing plus the SAMBA II HIV-1 Semiquantitative Whole Blood Test (SAMBA Semi-Q) and laboratory viral load testing. Persons with HIV from Madison Clinic were recruited into a randomized clinical trial (RCT) to compare the clinical standard of care with the addition of the SAMBA Semi-Q (backed up by Food and Drug Administration\u2013approved laboratory NAT). All participants completed a demographic survey during their study visit and contributed prospective data via electronic medical records. Subsets of participants from each group were invited to complete a postvisit acceptability survey and participate in an individual interview. Patient flow was observed at Madison Clinic to assess the impact of POC testing on clinic visit timing.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n From January 2022 to December 2024, 733 participants completed 753 GAIN research visits. Of those, 491 visits were completed by 489 participants seeking HIV testing and\/or PrEP at the Center, and 61 visits were completed by 43 participants seeking HIV testing, nonoccupational postexposure prophylaxis, and\/or PrEP at Madison Clinic. Test result data will assess test performance, with analyses anticipated in 2027. Seven people with HIV were enrolled at the Center, and 194 people with HIV were enrolled in the Madison Clinic RCT. Data from patients with HIV at Madison Clinic will be used to conduct a survival analysis evaluating the impact of POC NAT on time to viral suppression and to assess test performance, with analyses anticipated in 2026. In-depth acceptability surveys were completed by 193 participants, and 41 interviews were conducted. These data will contribute to qualitative and mixed methods analyses, which are anticipated in 2026. Time-and-motion observations conducted in 2021 and 2023 included 47 patients; results are anticipated in 2026.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The GAIN study is an important evaluation of POC NAT implementation in the United States in community and clinical care settings for HIV diagnosis and viral load monitoring. Results will be reported in future publications.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/84625","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:10:06Z","timestamp":1780949406000},"page":"e84625-e84625","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility, Acceptability, and Test Performance of Point-of-Care Nucleic Acid Tests for HIV Testing and Viral Load Monitoring in the United States: Prospective Longitudinal Mixed-Methods Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-8921","authenticated-orcid":false,"given":"Lisa A","family":"Niemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6469-7298","authenticated-orcid":false,"given":"Lauren R","family":"Violette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8908-123X","authenticated-orcid":false,"given":"Andy","family":"Cornelius-Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5716-158X","authenticated-orcid":false,"given":"Maggie","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9006-588X","authenticated-orcid":false,"given":"Carl","family":"Capili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-3379","authenticated-orcid":false,"given":"Mindy","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-1220","authenticated-orcid":false,"given":"Anjuli","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-9910","authenticated-orcid":false,"given":"Sarah","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-4011","authenticated-orcid":false,"given":"Shireesha","family":"Dhanireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6787-9003","authenticated-orcid":false,"given":"Shaneil E","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4942-7905","authenticated-orcid":false,"given":"Karen W","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8064-3011","authenticated-orcid":false,"given":"Joanne D","family":"Stekler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"1","key":"R1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1086\/315202","article-title":"Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection","volume":"181","author":"Malhotra","journal-title":"J Infect Dis"},{"issue":"6803","key":"R2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection","volume":"407","author":"Rosenberg","journal-title":"Nature"},{"issue":"3","key":"R3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1086\/315753","article-title":"Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection","volume":"182","author":"Smith","journal-title":"J Infect Dis"},{"issue":"9","key":"R4","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1086\/429411","article-title":"Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda","volume":"191","author":"Wawer","journal-title":"J Infect Dis"},{"issue":"17","key":"R5","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1097\/00002030-200111230-00010","article-title":"Acute HIV infection: impact on the spread of HIV and transmission of drug resistance","volume":"15","author":"Yerly","journal-title":"AIDS"},{"issue":"10","key":"R6","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/cid\/civ664","article-title":"Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia","volume":"61","author":"Kelley","journal-title":"Clin Infect Dis"},{"issue":"12","key":"R7","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/01.aids.0000238405.93249.16","article-title":"A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status","volume":"20","author":"Hutchinson","journal-title":"AIDS"},{"issue":"3","key":"R8","first-page":"348","volume":"38","author":"Spielberg","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"R9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1086\/600043","article-title":"HIV testing in a high-incidence population: is antibody testing alone good enough?","volume":"49","author":"Stekler","journal-title":"Clin Infect Dis"},{"issue":"2","key":"R10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.7326\/0003-4819-147-2-200707170-00022","article-title":"Negative rapid HIV antibody testing during early HIV infection","volume":"147","author":"Stekler","journal-title":"Ann Intern Med"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.12.011","article-title":"Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM","volume":"76","author":"Stekler","journal-title":"J Clin Virol"},{"issue":"0 1","key":"R12","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.jcv.2013.09.018","article-title":"Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men","volume":"58 Suppl 1","author":"Stekler","journal-title":"J Clin Virol"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1423-0410.1997.00011.x","article-title":"Sensitivity and specificity of standard and rapid HIV-antibody tests evaluated by seroconversion and non-seroconversion low-titre panels","volume":"72","author":"Kuun","journal-title":"Vox Sang"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0928-0197(96)00244-9","article-title":"Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1\/HIV-2 during seroconversion","volume":"7","author":"Samdal","journal-title":"Clin Diagn Virol"},{"issue":"2","key":"R15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0166-0934(02)00102-7","article-title":"Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV","volume":"105","author":"Beelaert","journal-title":"J Virol Methods"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1128\/JCM.02196-07","article-title":"Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States","volume":"46","author":"Owen","journal-title":"J Clin Microbiol"},{"issue":"8","key":"R17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/AID.2017.0276","article-title":"No time to delay! Fiebig stages and referral in acute HIV infection: Seattle primary infection program experience","volume":"34","author":"Stekler","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Suppl 1","key":"R18","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jcv.2013.07.002","article-title":"Performance of the Alere Determine\u2122 HIV-1\/2 Ag\/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast","volume":"58 Suppl 1","author":"Masciotra","journal-title":"J Clin Virol"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jviromet.2013.01.017","article-title":"Evaluation of the Determine\u2122 fourth generation HIV rapid assay","volume":"189","author":"Brauer","journal-title":"J Virol Methods"},{"issue":"10","key":"R20","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1128\/JCM.01989-14","article-title":"Poor performance of the determine HIV-1\/2 Ag\/Ab combo fourth-generation rapid test for detection of acute infections in a national household survey in Swaziland","volume":"52","author":"Duong","journal-title":"J Clin Microbiol"},{"issue":"6","key":"R21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218369","article-title":"Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care","volume":"14","author":"Agutu","journal-title":"PLOS One"},{"key":"R22","unstructured":"SAMBA II HIV-1 semi-quantitative whole blood test. Diagnostics for the Real World. URL: https:\/\/www.drw-ltd.com\/solutions\/tests\/item\/samba-ii-hiv-1-semi-q-whole-blood-test\/ [Accessed 21-04-2026]"},{"key":"R23","unstructured":"Xpert \u00ae HIV-1 qual XC a molecular point-of-care test that delivers results in around 90 minutes. Cepheid; 2018. URL: https:\/\/www.cepheid.com\/en-CZ\/tests\/blood-virology-womens-health-sexual-health\/xpert-hiv-1-qual.html [Accessed 21-04-2026]"},{"key":"R24","unstructured":"Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV. World Health Organization. URL: https:\/\/www.who.int\/publications\/i\/item\/9789240077089 [Accessed 21-04-2026]"},{"key":"R25","unstructured":"m-PIMA\u2122 HIV-1\/2 Detect. Abbott Point of Care. URL: https:\/\/www.globalpointofcare.abbott\/ww\/en\/product-details\/alere-q-hiv-12-detect.html [Accessed 21-04-2026]"},{"key":"R26","unstructured":"Alere q Analyser. Abbott Point of Care. URL: https:\/\/www.globalpointofcare.abbott\/ww\/en\/product-details\/alere-q-analyser.html [Accessed 21-04-2026]"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10384-2","article-title":"Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San Francisco","volume":"25","author":"Moore","journal-title":"BMC Infect Dis"},{"issue":"4","key":"R28","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/S2352-3018(19)30402-3","article-title":"Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial","volume":"7","author":"Drain","journal-title":"Lancet HIV"},{"issue":"1","key":"R29","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S2352-3018(17)30211-4","article-title":"Point-of-care viral load testing and differentiated HIV care","volume":"5","author":"Dorward","journal-title":"Lancet HIV"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05940-w","article-title":"Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa","volume":"20","author":"Msimango","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25663","article-title":"Evaluation of near point-of-care viral load implementation in public health facilities across seven countries in sub-Saharan Africa","volume":"24","author":"Boeke","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"R32","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25387","article-title":"Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi","volume":"22","author":"Nicholas","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08593-z","article-title":"\u201cAfter viral load testing, I get my results so I get to know which path my life is taking me\u201d: qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies","volume":"22","author":"Qian","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"R34","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14010072","article-title":"\u201cIt Soothes Your Heart\u201d: a multimethod study exploring acceptability of point-of-care viral load testing among Ugandan pregnant and postpartum women living with HIV","volume":"14","author":"Nakyanzi","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"R35","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1093\/cid\/ciaf510","article-title":"The critical importance of clinical use case to inform point-of-care technology development: a case study of HIV nucleic acid assays in the United States","volume":"82","author":"Manabe","journal-title":"Clin Infect Dis"},{"issue":"6","key":"R36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270302","article-title":"Provider perspectives on the use of motivational interviewing and problem-solving counseling paired with the point-of-care nucleic acid test for HIV care","volume":"17","author":"Atkins","journal-title":"PLoS One"},{"key":"R37","unstructured":"Lisa A. Niemann MSW Lauren R. Violette MPH Andy Cornelius-Hudson BA et al. Patient Flow Assessed In Preparation For Point-Of-Care HIV Nucleic Acid Testing (POC NAT) Implementation At A Large HIV Clinic In Seattle. 2022."},{"issue":"5","key":"R38","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/QAI.0000000000001621","article-title":"HIV pre-exposure prophylaxis prescribing through telehealth","volume":"77","author":"Stekler","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"R39","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac670","article-title":"The impact of a walk-in human immunodeficiency virus care model for people who are incompletely engaged in care: The Moderate Needs (MOD) Clinic","volume":"10","author":"Kumbhakar","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"R40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/apc.2017.0313","article-title":"The Max Clinic: medical care designed to engage the hardest-to-reach persons living with HIV in Seattle and King County, Washington","volume":"32","author":"Dombrowski","journal-title":"AIDS Patient Care STDS"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105127","article-title":"Performance assessment of the new Xpert\u00ae HIV-1 viral load XC assay for quantification of HIV-1 viral loads","volume":"149","author":"Ehret","journal-title":"J Clin Virol"},{"key":"R42","unstructured":"SAMBA II HIV-1 Qualitative Whole Blood Test. Diagnostics for the Real World. URL: https:\/\/www.drw-ltd.com\/solutions\/tests\/item\/samba-ii-hiv-1-qualitative-whole-blood-test\/ [Accessed 21-04-2026]"},{"key":"R43","unstructured":"About. ITHS. URL: https:\/\/www.iths.org\/about\/ [Accessed 24-01-2026]"},{"issue":"1","key":"R44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/157016207779316369","article-title":"Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients","volume":"5","author":"Crane","journal-title":"Curr HIV Res"},{"issue":"5","key":"R45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/QAI.0000000000002902","article-title":"Evaluation of SAMBA II: A qualitative and semiquantitative HIV point-of-care nucleic acid test","volume":"89","author":"Violette","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"R46","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.aids.0000180105.73264.81","article-title":"Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men","volume":"19","author":"Stekler","journal-title":"AIDS"},{"issue":"9","key":"R47","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2105\/AJPH.2015.302659","article-title":"HIV testing by transgender status at centers for disease control and prevention-funded sites in the United States, Puerto Rico, and US Virgin Islands, 2009-2011","volume":"105","author":"Habarta","journal-title":"Am J Public Health"},{"issue":"2","key":"R48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/OLQ.0000000000000917","article-title":"Chlamydia, gonorrhea, and human immunodeficiency virus infection among transgender women and transgender men attending clinics that provide sexually transmitted disease services in six US cities: results from the sexually transmitted disease surveillance network","volume":"46","author":"Pitasi","journal-title":"Sex Transm Dis"},{"key":"R49","unstructured":"HIV\/AIDS data. King County, Washington. URL: https:\/\/kingcounty.gov\/en\/dept\/dph\/health-safety\/disease-illness\/hiv-sti-hcv\/data-reports\/annual-reports [Accessed 22-12-2025]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:26:00Z","timestamp":1785536760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":49,"URL":"https:\/\/doi.org\/10.2196\/84625","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"v15i1e84625"}}